Solveig Norheim Andersen

Solveig Norheim Andersen is a scientific researcher affiliated with the Clinic for Internal Medicine and Laboratory Sciences at Akershus University Hospital and the Faculty of Medicine at the University of Oslo. She has been consistently active in medical research from the 1970s to the present, with a focus on gastrointestinal pathology and cancer biology.

Her research interests are deeply rooted in molecular pathology, particularly in colorectal cancer, ulcerative colitis, and inflammatory bowel disease. She investigates key molecular markers such as K-ras mutations, p53 alterations, microsatellite instability, NUCKS1, and HER2 signaling, often in the context of cancer progression and patient prognosis. Her work bridges clinical pathology with translational research, aiming to improve diagnostic accuracy and therapeutic strategies.

The recent articles highlight a strong trend in oncology, surgical pathology, and molecular diagnostics, with increasing emphasis on biomarker validation, cancer staging refinement, and surveillance techniques in gastrointestinal diseases. Her publications span high-impact journals in gastroenterology, oncology, and molecular pathology, reflecting interdisciplinary collaboration and clinical relevance.

She has collaborated extensively with leading researchers including Ole Petter Clausen, Paula De Angelis, Tone Løvig, and Torleiv Rognum, and has contributed to multicenter clinical trials in colorectal cancer. Her work in D3 mesenterectomy, lymph node micrometastases, and preoperative anatomical mapping has contributed to surgical oncology practices.

Dr. Andersen has been involved in research groups such as the Pathology group at Ahus, indicating leadership and sustained engagement in laboratory-based and clinical research. While no formal awards or students are listed, her long publication history and senior authorship positions suggest mentorship and recognition within the field.